Page last updated: 2024-09-04

pyroglutamyl-phenylalanyl-prolinamide and triiodothyronine

pyroglutamyl-phenylalanyl-prolinamide has been researched along with triiodothyronine in 1 studies

Compound Research Comparison

Studies
(pyroglutamyl-phenylalanyl-prolinamide)
Trials
(pyroglutamyl-phenylalanyl-prolinamide)
Recent Studies (post-2010)
(pyroglutamyl-phenylalanyl-prolinamide)
Studies
(triiodothyronine)
Trials
(triiodothyronine)
Recent Studies (post-2010) (triiodothyronine)
90026,2478613,473

Protein Interaction Comparison

ProteinTaxonomypyroglutamyl-phenylalanyl-prolinamide (IC50)triiodothyronine (IC50)
Thyroid hormone receptor alphaHomo sapiens (human)0.0006
Thyroid hormone receptor betaHomo sapiens (human)0.0006
Proliferating cell nuclear antigenHomo sapiens (human)3.6
Thyroid hormone receptor betaRattus norvegicus (Norway rat)0.0031
Adenosine receptor A1Homo sapiens (human)0.4109

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremades, A; Del Rio-Garcia, J; PeƱafiel, R; Rausell, V; Smyth, DG1

Other Studies

1 other study(ies) available for pyroglutamyl-phenylalanyl-prolinamide and triiodothyronine

ArticleYear
The thyrotropin-releasing hormone-like peptides pGlu-Phe-Pro amide and pGlu-Glu-Pro amide increase plasma triiodothyronine levels in the mouse; the activity is sensitive to testosterone.
    European journal of pharmacology, 1998, Sep-25, Volume: 358, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Castration; Female; Male; Mice; Oligopeptides; Pyrrolidonecarboxylic Acid; Testosterone; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1998